Results by Type

News Results 1-10 of 1,575

Timeframe:

All | 90 days | 30 days | 7 days | Last 24 hours

Sort by:

Date | Relevance

Taming the Wild Child

Make your RAD and/or ODD child easy to live with

www.RadConsultancy.com

Anxiety Disorders

Anxiety Disorder Help For Girls Intensive Inpatient Programs

www.remudaranch.com

Access HealthColumbus looking for group to run charity pharmacy

News | www.bizjournals.com | 12 hours 46 minutes ago

A Columbus health-care advocacy group is seeking an organization willing to run a “pharmacy of last resort” to distribute free drugs to people for whom even $4 generic prescriptions can cost too much.

http://www.bizjournals.com/columbus/stories/2008/10/13/story11.html?ana=from_rss

Irish Medical Times | Clinical TImes | Doctors miss their chance to empathise

News | www.imt.ie | Oct 11, 2008

A small study has found that doctors seldom respond empathetically to concerns raised by patients with lung cancer. In the study, doctors analysed 20 recorded and transcribed consultations between lung cancer patients and nine doctors.

http://www.imt.ie/clinical/cancer/doctors-miss-their-chance-to-e.html

Europese informatiecampagne over gezonde werkplek

News | www.gezondheid.be | Oct 10, 2008

Jaarlijks sterven duizenden mensen in de Europese Unie aan de gevolgen van een arbeidsongeval of een beroepsziekte. Elk jaar sterven 5.720 mensen in de Europese Unie aan de gevolgen van een arbeidsongeval.

http://www.gezondheid.be/index.cfm?fuseaction=art&art_id=5844

Shionogi Completes Acquisition of Sciele (Business Wire)

News | biz.yahoo.com | Oct 9, 2008

Shionogi Completes Acquisition of Sciele. - OSAKA, Japan & ATLANTA--(BUSINESS WIRE)--On October 9, 2008, Shionogi & Co., Ltd. (“Shionogi”) and Sciele Pharma, Inc. (“Sciele”) (NASDAQ: SCRX - News) announced the completion of Shionogi’s acquisition of Sciele for US$31.00 per share in cash.

http://biz.yahoo.com/bw/081009/20081009005820.html?.v=1

Cenomed, Inc. and TorreyPines Therapeutics, Inc.'s Enter into Licensing Agreement

News | www.biospace.com | Oct 8, 2008

IRVINE, Calif. & LA JOLLA, Calif.--(BUSINESS WIRE)--Cenomed BioSciences, LLC, a majority-owned subsidiary of Abraxis BioScience, Inc. (Nasdaq: ABII - News), and TorreyPines Therapeutics, Inc. (Nasdaq: TPTX - News) today announced that they have entered into an exclusive licensing agreement whereby

http://www.biospace.com/news_story.aspx?StoryID=112243&full=1

Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD

Press Release | www.prnewswire.com | Oct 7, 2008

This study is the phase 3 pivotal trial submitted to the FDA and supported the approval in April 2008 of VYVANSE for adults with ADHD.

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/10-07-2008/0004899337&EDATE=

Safer prenatal Down's syndrome test found in U.S

News | uk.reuters.com | Oct 6, 2008

WASHINGTON (Reuters) - A prenatal blood test can be used to determine if an unborn baby has Down's syndrome without the small risk to the fetus posed by invasive testing methods such as amniocentesis,

http://uk.reuters.com/article/healthNews/idUKTRE4957RF20081006?feedType=RSS&feedName=healthNews

Inside health - What next now the drugs don't work?

News | news.scotsman.com | Sep 25, 2008

Inside health - What next now the drugs don't work? - SO THE drugs often dubbed the "chemical cosh" because of their calming effects on hyperactive children are not the panacea many had hoped for.

http://news.scotsman.com/health/Inside-health--What-next.4525818.jp

U.K. Urges Restraint In Using ADHD Drugs (at The Wall Street Journal Online)

News | online.wsj.com | Sep 24, 2008

Dow Jones Reprints: This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool at the bottom of any article or visit www.djreprints.com See a sample reprint in PDF format.

http://online.wsj.com/article/SB122228540367072247.html?mod=yahoo_hs&ru=yahoo